Avène and ORIGA’s Artificial Intelligence : a new era for clinical studies in dermo-cosmetics

📣 The Pierre Fabre Group announces a major breakthrough with its Avène brand, which is integrating the artificial intelligence of our ORIGA platform to transform the conduct of clinical trials in dermo-cosmetics.

🔬 The GOAL:
To leverage the power of Human-Centered Artificial Intelligence (HCAI) to improve the quality, accuracy, and speed of clinical trials, particularly in the evaluation of dermatological products. Thanks to ORIGA, researchers can analyze patient data more precisely, optimize trial monitoring, and better understand skin reactions under real-world conditions.

💡 This innovative approach notably enables:

• accelerating the development of new products

• improving the scientific robustness of studies

• addressing the challenge of the required number of patients for a multicenter clinical trial within a limited timeframe.